Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Imfinzi (durvalumab) for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer

On June 14, 2024, the Food and Drug Administration approved Imfinzi (durvalumab), AstraZeneca UK Limited, with carboplatin plus paclitaxel followed by...

FDA Approves Blincyto (blinatumomab) in CD19-Positive Philadelphia Chromosome-Negative B-ALL in the Consolidation Phase

Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved Blincyto (blinatumomab) for the treatment of adult and...

FDA Approves Adbry (tralokinumab-ldrm) Autoinjector for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis (AD)

(BUSINESS WIRE)-- June 13, 2024. LEO Pharma Inc. has today announced approval from the U.S. Food and Drug Administration (FDA) for a new Adbry (tralokinumab-ldrm)...

FDA Approves Farxiga (dapagliflozin) for Glycemic Control in Children Aged 10 Years and Older with Type-2 Diabetes

12 June 2024 – AstraZeneca’s Farxiga (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycaemic control...

FDA Grants Accelerated Approval to Iqirvo (elafibranor) for the Treatment of Primary Biliary Cholangitis

PARIS, FRANCE, 10 June 2024: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated...

2008 to 2021 Saw Increase in Prevalence of Chronic HTN in Pregnancy

For pregnant individuals, the prevalence of chronic hypertension more than doubled between 2008 and 2021, according to a study published online June 17...

Xylitol Linked to Incident Major Adverse Cardiovascular Event Risk

Xylitol is associated with incident major adverse cardiovascular event (MACE) risk, according to a study published online June 6 in the European Heart...

Teens, Young Adults Modify Electronic Nicotine Delivery Systems

Adolescents and young adults (AYAs) are aware of and engage in modifications of electronic nicotine delivery systems (ENDS), according to a study published...

Few Receive Meds for Opioid Use Disorder After Nonfatal Overdose

In the 12 months after a nonfatal overdose, few Medicare beneficiaries receive medications for opioid use disorder (MOUD) or fill a naloxone prescription,...

Inherited Alzheimer's: Whether It's From Mom or Dad Could Matter

Genetics can play a role in a person's odds for Alzheimer's disease, and new research suggests differences in that risk are based on which parent had the...

Surgeon General Calls for Warning Labels on Social Media Sites

The U.S. Surgeon General announced Monday that he will push for warning labels on all social media platforms, stating that they may harm teens' mental...

There May Be 6 Types of Depression, and Brain Scans Can Sort Them Out

Depression can be sorted into six distinct types using brain scans, a revelation that could improve treatment for many suffering the debilitating mood...

Trouble Getting Your Kids to Sleep? You're Not Alone, Poll Finds

Nearly 1 in 4 parents struggle to get their child to sleep, a new poll reports. Some of this is related to poor sleep hygiene, but some also is due to...

New CIMZIA data for women living with chronic rheumatic diseases throughout pregnancy, and for people living with RA and high rheumatoid factor levels

ATLANTA, June 13, 2024. UCB, a global biopharmaceutical company, will present results from three studies for CIMZIA (certolizumab pegol), a PEGylated fragment...

Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity

CRANBURY, N.J., June 12, 2024. Palatin Technologies, Inc., a biopharmaceutical company developing first-in-class medicines based on molecules that modulate...

Exercise at One Time of Day Might Be Best for Blood Sugar Control

Folks trying to control their blood sugar levels might do best to work out in the evening, a new study suggests. Exercise performed between 6 p.m. and...

Male Enhancement Supplements Recalled

Integrity Products , St Louis MO is voluntarily recalling tainted lot (HGW221116) within expiry of the Ram It & To The Moon capsules to the consumer...

Read more news...

Recently Added

Recently added consumer and prescribing information: Iqirvo, Rytelo, mRESVIA, Bkemv, Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Iqirvo Iqirvo (elafibranor) is a dual peroxisome-activated receptor (PPAR) alpha/delta (α,δ) agonist used for the treatment of patients with p...
  • Rytelo Rytelo (imetelstat) is an oligonucleotide telomerase inhibitor indicated for the treatment of adult patients with low- to intermediate-1...
  • mRESVIA mRESVIA is a modified RNA vaccine that may protect adults aged 60 years and older from lower respiratory tract disease caused by an RSV infection.

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development